The phosphoinositide 3‐kinase (PI3K), AKT (also known as protein kinase B, PKB) and mammalian target of rapamycin (mTOR), dominate various indications of cancer including cell cycle, survival, metabolism, motility, and genomic instability. This evidence concerns the gene AKT1 and cancer.